SEGMENT REPORTING - Schedule of Revenue from External Customers by Products and Services (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	May 31, 2026	May 31, 2025	May 31, 2026	May 31, 2025
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]
Revenues	$ 21,886	$ 20,363	$ 64,598	$ 61,719
Product Concentration Risk \| Revenue from Contract with Customer, Product and Service Benchmark
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]
Concentration risk, percentage	100.00%	100.00%	100.00%	100.00%
Total Software
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]
Revenues	$ 12,608	$ 12,615	$ 36,126	$ 36,814
Total Software \| Product Concentration Risk \| Revenue from Contract with Customer, Product and Service Benchmark
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]
Concentration risk, percentage	100.00%	100.00%	100.00%	100.00%
Total Services
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]
Revenues	$ 9,278	$ 7,748	$ 28,472	$ 24,905
Total Services \| Product Concentration Risk \| Revenue from Contract with Customer, Product and Service Benchmark
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]
Concentration risk, percentage	100.00%	100.00%	100.00%	100.00%
Discovery \| Total Software
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]
Revenues	$ 2,484	$ 2,527	$ 6,540	$ 6,130
Discovery \| Total Software \| Product Concentration Risk \| Revenue from Contract with Customer, Product and Service Benchmark
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]
Concentration risk, percentage	20.00%	20.00%	18.00%	17.00%
Discovery \| Total Services
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]
Revenues	$ 0	$ 0	$ 35	$ 50
Discovery \| Total Services \| Product Concentration Risk \| Revenue from Contract with Customer, Product and Service Benchmark
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]
Concentration risk, percentage	0.00%	0.00%	0.00%	0.00%
Development \| Total Software
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]
Revenues	$ 9,813	$ 9,631	$ 28,497	$ 27,513
Development \| Total Software \| Product Concentration Risk \| Revenue from Contract with Customer, Product and Service Benchmark
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]
Concentration risk, percentage	78.00%	77.00%	79.00%	75.00%
Development \| Total Services
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]
Revenues	$ 7,255	$ 5,768	$ 21,407	$ 18,651
Development \| Total Services \| Product Concentration Risk \| Revenue from Contract with Customer, Product and Service Benchmark
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]
Concentration risk, percentage	78.00%	74.00%	75.00%	75.00%
Clinical Operations \| Total Software
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]
Revenues	$ 277	$ 416	$ 992	$ 2,995
Clinical Operations \| Total Software \| Product Concentration Risk \| Revenue from Contract with Customer, Product and Service Benchmark
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]
Concentration risk, percentage	2.00%	3.00%	3.00%	8.00%
Commercialization \| Total Software
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]
Revenues	$ 34	$ 41	$ 97	$ 176
Commercialization \| Total Software \| Product Concentration Risk \| Revenue from Contract with Customer, Product and Service Benchmark
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]
Concentration risk, percentage	0.00%	0.00%	0.00%	0.00%
Commercialization \| Total Services
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]
Revenues	$ 2,023	$ 1,980	$ 7,030	$ 6,204
Commercialization \| Total Services \| Product Concentration Risk \| Revenue from Contract with Customer, Product and Service Benchmark
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]
Concentration risk, percentage	22.00%	26.00%	25.00%	25.00%